Xiaowei Wang

1.6k total citations · 1 hit paper
93 papers, 1.1k citations indexed

About

Xiaowei Wang is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Xiaowei Wang has authored 93 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 35 papers in Infectious Diseases and 32 papers in Organic Chemistry. Recurrent topics in Xiaowei Wang's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (14 papers) and Synthesis and biological activity (10 papers). Xiaowei Wang is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (14 papers) and Synthesis and biological activity (10 papers). Xiaowei Wang collaborates with scholars based in China, United States and Hong Kong. Xiaowei Wang's co-authors include Wenbin Zhang, Zhili Zhang, Chao Tian, Junyi Liu, Manyu Liu, Yanan Zhu, Chaohong Zhang, Hong Meng, Junyi Liu and Yaowu He and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Chemistry of Materials.

In The Last Decade

Xiaowei Wang

85 papers receiving 1.1k citations

Hit Papers

An Ultrafast, Energy‐Efficient Electrochromic and Thermoc... 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Ultrafast, Energy‐Efficient Electrochromic and Thermochromic Device for Smart Windows
    2023 163 citations Yanan Zhu, Xiaowei Wang et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Wang China 19 388 369 172 162 140 93 1.1k
Liwei Cao China 19 169 0.4× 575 1.6× 112 0.7× 97 0.6× 191 1.4× 32 1.2k
Liang Sun China 22 416 1.1× 644 1.7× 264 1.5× 117 0.7× 220 1.6× 78 1.8k
Antons Sizovs United States 18 142 0.4× 583 1.6× 56 0.3× 75 0.5× 231 1.6× 24 1.2k
Ravi Kant India 18 216 0.6× 303 0.8× 84 0.5× 71 0.4× 109 0.8× 103 1.2k
Abhay Asthana India 19 346 0.9× 999 2.7× 826 4.8× 61 0.4× 218 1.6× 31 1.9k
Na Ni China 19 49 0.1× 402 1.1× 46 0.3× 82 0.5× 152 1.1× 74 997
Zhi Chen China 21 238 0.6× 661 1.8× 37 0.2× 44 0.3× 449 3.2× 66 1.6k

Countries citing papers authored by Xiaowei Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Wang more than expected).

Fields of papers citing papers by Xiaowei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Wang. The network helps show where Xiaowei Wang may publish in the future.

Co-authorship network of co-authors of Xiaowei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Wang. A scholar is included among the top collaborators of Xiaowei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Wang. Xiaowei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Refaat, Ahmed, et al.. (2025). Acetylcholine-loaded nanoparticles protect against doxorubicin-induced toxicity in in vitro cardiac spheroids. Biofabrication. 17(2). 25023–25023. 1 indexed citations
2.
3.
Wang, Xiaowei, et al.. (2025). Self‐assembly Strategies Driven by Supramolecular RAFT Polymerization: Pseudorotaxanes and Nanosheets. Chinese Journal of Chemistry. 43(13). 1495–1503.
4.
Wang, Xiaowei, Wenjing Qiu, Guangli Hu, et al.. (2024). NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production. Journal of Virology. 98(5). e0031724–e0031724. 4 indexed citations
5.
Wang, Xiaowei, et al.. (2024). Faulty feeder detection based on the fluctuation characteristics of inflection point dense area for DC distribution network. Electric Power Systems Research. 233. 110510–110510. 3 indexed citations
6.
Wang, Xiaowei, et al.. (2024). Neuroprotective properties of the Lilium brownii extracts in the experimental model of Parkinson’s disease. Metabolic Brain Disease. 39(6). 1085–1097.
7.
Zhu, Yanan, Xiaowei Wang, Jinlin Zhu, et al.. (2023). An Ultrafast, Energy‐Efficient Electrochromic and Thermochromic Device for Smart Windows. Advanced Materials. 35(35). e2302685–e2302685. 163 indexed citations breakdown →
8.
Follmann, Dean, Xiaowei Wang, Peter B. Gilbert, et al.. (2023). 1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves. Open Forum Infectious Diseases. 10(Supplement_2).
9.
Tian, Chao, et al.. (2022). Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent. European Journal of Medicinal Chemistry. 238. 114466–114466. 8 indexed citations
10.
Huang, Kang, Derek W. Dunn, Xi Yang, et al.. (2020). MHC-Based Mate Choice in Wild Golden Snub-Nosed Monkeys. Frontiers in Genetics. 11. 609414–609414. 7 indexed citations
11.
Yang, Zhongguang, Songzi Kou, Xi Wei, et al.. (2018). Genetically Programming Stress-Relaxation Behavior in Entirely Protein-Based Molecular Networks. ACS Macro Letters. 7(12). 1468–1474. 27 indexed citations
12.
Hao, Yameng, et al.. (2018). Study on Dual Inhibitors of HIV‐1 IN/CCR5 Caffeoyl Derivatives as Neuroprotective Agents. ChemistrySelect. 3(22). 6170–6173. 1 indexed citations
13.
Tian, Chao, Meng Wang, Fang Fang, et al.. (2017). Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2- d ] pyrimidine analogues as antifolate antitumor agents. European Journal of Medicinal Chemistry. 138. 630–643. 21 indexed citations
14.
Ning, Xianling, Mengmeng Yuan, Ying Guo, et al.. (2015). Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivativesin vitromodels of Parkinson's disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(3). 1–6. 7 indexed citations
15.
16.
Zhang, Zhili, Chao Tian, Wei Wang, et al.. (2012). Mechanism-based design, synthesis and biological studies of N5-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents. European Journal of Medicinal Chemistry. 58. 228–236. 22 indexed citations
17.
Qin, Hua, Chang Liu, Ying Guo, et al.. (2010). Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 18(9). 3231–3237. 20 indexed citations
18.
Chen, Wenjing, et al.. (2010). Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis. Journal of Chromatography B. 878(20). 1714–1717. 10 indexed citations
19.
20.
Lu, Xiao, Yanli Chen, Ying Guo, et al.. (2007). The design and synthesis of N-1-alkylated-5-aminoaryalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. Bioorganic & Medicinal Chemistry. 15(23). 7399–7407. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liwei Cao Breakdown of academic impact, for papers by Liang Sun Breakdown of academic impact, for papers by Antons Sizovs Breakdown of academic impact, for papers by Ravi Kant Breakdown of academic impact, for papers by Abhay Asthana Breakdown of academic impact, for papers by Na Ni Breakdown of academic impact, for papers by Zhi Chen
Rankless by CCL
2026